The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.
Identifieur interne : 002B49 ( PubMed/Curation ); précédent : 002B48; suivant : 002B50The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.
Auteurs : Sheila F. O'Brien [Canada] ; Gilles Delage [Canada] ; Clive R. Seed [Australie] ; Josiane Pillonel [France] ; Cécile C. Fabra [France] ; Katy Davison [Royaume-Uni] ; Alan Kitchen [Royaume-Uni] ; Whitney R. Steele [États-Unis] ; David A. Leiby [États-Unis]Source :
- Transfusion medicine reviews [ 1532-9496 ] ; 2015.
Descripteurs français
- KwdFr :
- Afrique (épidémiologie), Angleterre (épidémiologie), Australie (épidémiologie), Canada (épidémiologie), Donneurs de sang, France (épidémiologie), Humains, Maladies endémiques, Paludisme (), Paludisme (diagnostic), Paludisme (transmission), Paludisme (épidémiologie), Politique de santé, Surveillance de la santé publique, Sécurité transfusionnelle (), Sécurité transfusionnelle (normes), Sélection de donneurs (normes), Transfusion sanguine (effets indésirables), Transfusion sanguine (normes), Voyage, Émigration et immigration, États-Unis d'Amérique (épidémiologie).
- MESH :
- diagnostic : Paludisme.
- effets indésirables : Transfusion sanguine.
- normes : Sécurité transfusionnelle, Sélection de donneurs, Transfusion sanguine.
- épidémiologie : Afrique, Angleterre, Australie, Canada, France, Paludisme, États-Unis d'Amérique.
- Donneurs de sang, Humains, Maladies endémiques, Paludisme, Politique de santé, Surveillance de la santé publique, Sécurité transfusionnelle, Voyage, Émigration et immigration.
- Wicri :
- geographic : Australie, Canada, France, États-Unis.
English descriptors
- KwdEn :
- Africa (epidemiology), Australia (epidemiology), Blood Donors, Blood Safety (methods), Blood Safety (standards), Blood Transfusion (adverse effects), Blood Transfusion (standards), Canada (epidemiology), Donor Selection (standards), Emigration and Immigration, Endemic Diseases, England (epidemiology), France (epidemiology), Health Policy, Humans, Malaria (diagnosis), Malaria (epidemiology), Malaria (prevention & control), Malaria (transmission), Public Health Surveillance, Travel, United States (epidemiology).
- MESH :
- geographic , epidemiology : Africa, Australia, Canada, England, France, United States.
- adverse effects : Blood Transfusion.
- diagnosis : Malaria.
- epidemiology : Malaria.
- methods : Blood Safety.
- prevention & control : Malaria.
- standards : Blood Safety, Blood Transfusion, Donor Selection.
- transmission : Malaria.
- Blood Donors, Emigration and Immigration, Endemic Diseases, Health Policy, Humans, Public Health Surveillance, Travel.
Abstract
Addressing risk of imported malaria is complicated by 5 human species of Plasmodium, semi-immunity in donors with long-term exposure, increasing travel and immigration, changing risk in endemic areas, and limitations of screening assays. To gain insight into policy formulation, we have compiled epidemiologic data from 5 countries with different policies involving either deferral (the United States and Canada) or selective testing (France, England, and Australia). The greatest risk is from semi-immune former residents of endemic areas, but the greatest impact on sufficiency (donor loss) is from low-risk short-term travel. France and the UK have the highest rates of travel to Africa where most malaria cases originate. The UK has substantial travel to the Indian subcontinent where Plasmodium vivax cases are more common, and Australia, to Southeast Asia and Papua New Guinea. In the United States and Canada, malaria risk travel is more often to lower risk areas such as Mexico and the Caribbean. Each country has imported cases, predominantly Plasmodium falciparum and P. vivax, although data are incomplete. Transfusion-transmitted malaria has been rare over the last 10 years, generally involving P. falciparum, but there were 2 US cases of Plasmodium malariae. Uncertainty due to limitations of epidemiologic data and reliance on donors' answers underpins much of the complexity of policy formulation. Variability in policies between countries reflects not only epidemiologic differences but also operational considerations, donor demographics, regulatory approaches, and public pressure to react to rare transfusion-transmitted malaria cases. Testing reduces the operational impact of addressing the very small risk from travelers and offers improvement over deferral by testing all former residents of endemic areas. Notwithstanding current international regulatory requirements, policies have "evolved" through a series of additions and revisions as concerns and issues arose, with resultant variability in donor selection criteria.
DOI: 10.1016/j.tmrv.2015.03.004
PubMed: 25933591
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002C22
Links to Exploration step
pubmed:25933591Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.</title><author><name sortKey="O Brien, Sheila F" sort="O Brien, Sheila F" uniqKey="O Brien S" first="Sheila F" last="O'Brien">Sheila F. O'Brien</name><affiliation wicri:level="1"><nlm:affiliation>Canadian Blood Services Ottawa, Ontario, Canada. Electronic address: sheila.obrien@blood.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Canadian Blood Services Ottawa, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Delage, Gilles" sort="Delage, Gilles" uniqKey="Delage G" first="Gilles" last="Delage">Gilles Delage</name><affiliation wicri:level="1"><nlm:affiliation>Héma-Québec Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Héma-Québec Montreal, Quebec</wicri:regionArea></affiliation></author><author><name sortKey="Seed, Clive R" sort="Seed, Clive R" uniqKey="Seed C" first="Clive R" last="Seed">Clive R. Seed</name><affiliation wicri:level="1"><nlm:affiliation>Australian Red Cross Blood Service Perth, Western Australia, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Australian Red Cross Blood Service Perth, Western Australia</wicri:regionArea></affiliation></author><author><name sortKey="Pillonel, Josiane" sort="Pillonel, Josiane" uniqKey="Pillonel J" first="Josiane" last="Pillonel">Josiane Pillonel</name><affiliation wicri:level="1"><nlm:affiliation>Institut de Veille Sanitaire, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut de Veille Sanitaire, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Fabra, Cecile C" sort="Fabra, Cecile C" uniqKey="Fabra C" first="Cécile C" last="Fabra">Cécile C. Fabra</name><affiliation wicri:level="1"><nlm:affiliation>Établissement Français du Sang Tours, Indre-et-Loire, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Établissement Français du Sang Tours, Indre-et-Loire</wicri:regionArea></affiliation></author><author><name sortKey="Davison, Katy" sort="Davison, Katy" uniqKey="Davison K" first="Katy" last="Davison">Katy Davison</name><affiliation wicri:level="1"><nlm:affiliation>Health Protection Agency, Centre for Infections, London, UK; NHS Blood and Transplant, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Health Protection Agency, Centre for Infections, London, UK; NHS Blood and Transplant, London</wicri:regionArea></affiliation></author><author><name sortKey="Kitchen, Alan" sort="Kitchen, Alan" uniqKey="Kitchen A" first="Alan" last="Kitchen">Alan Kitchen</name><affiliation wicri:level="1"><nlm:affiliation>NHS Blood and Transplant, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>NHS Blood and Transplant, London</wicri:regionArea></affiliation></author><author><name sortKey="Steele, Whitney R" sort="Steele, Whitney R" uniqKey="Steele W" first="Whitney R" last="Steele">Whitney R. Steele</name><affiliation wicri:level="1"><nlm:affiliation>American Red Cross Holland Laboratory, Rockville, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>American Red Cross Holland Laboratory, Rockville, MD</wicri:regionArea></affiliation></author><author><name sortKey="Leiby, David A" sort="Leiby, David A" uniqKey="Leiby D" first="David A" last="Leiby">David A. Leiby</name><affiliation wicri:level="1"><nlm:affiliation>American Red Cross Holland Laboratory, Rockville, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>American Red Cross Holland Laboratory, Rockville, MD</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25933591</idno><idno type="pmid">25933591</idno><idno type="doi">10.1016/j.tmrv.2015.03.004</idno><idno type="wicri:Area/PubMed/Corpus">002C22</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C22</idno><idno type="wicri:Area/PubMed/Curation">002B49</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B49</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.</title><author><name sortKey="O Brien, Sheila F" sort="O Brien, Sheila F" uniqKey="O Brien S" first="Sheila F" last="O'Brien">Sheila F. O'Brien</name><affiliation wicri:level="1"><nlm:affiliation>Canadian Blood Services Ottawa, Ontario, Canada. Electronic address: sheila.obrien@blood.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Canadian Blood Services Ottawa, Ontario</wicri:regionArea></affiliation></author><author><name sortKey="Delage, Gilles" sort="Delage, Gilles" uniqKey="Delage G" first="Gilles" last="Delage">Gilles Delage</name><affiliation wicri:level="1"><nlm:affiliation>Héma-Québec Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Héma-Québec Montreal, Quebec</wicri:regionArea></affiliation></author><author><name sortKey="Seed, Clive R" sort="Seed, Clive R" uniqKey="Seed C" first="Clive R" last="Seed">Clive R. Seed</name><affiliation wicri:level="1"><nlm:affiliation>Australian Red Cross Blood Service Perth, Western Australia, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Australian Red Cross Blood Service Perth, Western Australia</wicri:regionArea></affiliation></author><author><name sortKey="Pillonel, Josiane" sort="Pillonel, Josiane" uniqKey="Pillonel J" first="Josiane" last="Pillonel">Josiane Pillonel</name><affiliation wicri:level="1"><nlm:affiliation>Institut de Veille Sanitaire, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institut de Veille Sanitaire, Paris</wicri:regionArea></affiliation></author><author><name sortKey="Fabra, Cecile C" sort="Fabra, Cecile C" uniqKey="Fabra C" first="Cécile C" last="Fabra">Cécile C. Fabra</name><affiliation wicri:level="1"><nlm:affiliation>Établissement Français du Sang Tours, Indre-et-Loire, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Établissement Français du Sang Tours, Indre-et-Loire</wicri:regionArea></affiliation></author><author><name sortKey="Davison, Katy" sort="Davison, Katy" uniqKey="Davison K" first="Katy" last="Davison">Katy Davison</name><affiliation wicri:level="1"><nlm:affiliation>Health Protection Agency, Centre for Infections, London, UK; NHS Blood and Transplant, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Health Protection Agency, Centre for Infections, London, UK; NHS Blood and Transplant, London</wicri:regionArea></affiliation></author><author><name sortKey="Kitchen, Alan" sort="Kitchen, Alan" uniqKey="Kitchen A" first="Alan" last="Kitchen">Alan Kitchen</name><affiliation wicri:level="1"><nlm:affiliation>NHS Blood and Transplant, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>NHS Blood and Transplant, London</wicri:regionArea></affiliation></author><author><name sortKey="Steele, Whitney R" sort="Steele, Whitney R" uniqKey="Steele W" first="Whitney R" last="Steele">Whitney R. Steele</name><affiliation wicri:level="1"><nlm:affiliation>American Red Cross Holland Laboratory, Rockville, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>American Red Cross Holland Laboratory, Rockville, MD</wicri:regionArea></affiliation></author><author><name sortKey="Leiby, David A" sort="Leiby, David A" uniqKey="Leiby D" first="David A" last="Leiby">David A. Leiby</name><affiliation wicri:level="1"><nlm:affiliation>American Red Cross Holland Laboratory, Rockville, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>American Red Cross Holland Laboratory, Rockville, MD</wicri:regionArea></affiliation></author></analytic><series><title level="j">Transfusion medicine reviews</title><idno type="eISSN">1532-9496</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Africa (epidemiology)</term><term>Australia (epidemiology)</term><term>Blood Donors</term><term>Blood Safety (methods)</term><term>Blood Safety (standards)</term><term>Blood Transfusion (adverse effects)</term><term>Blood Transfusion (standards)</term><term>Canada (epidemiology)</term><term>Donor Selection (standards)</term><term>Emigration and Immigration</term><term>Endemic Diseases</term><term>England (epidemiology)</term><term>France (epidemiology)</term><term>Health Policy</term><term>Humans</term><term>Malaria (diagnosis)</term><term>Malaria (epidemiology)</term><term>Malaria (prevention & control)</term><term>Malaria (transmission)</term><term>Public Health Surveillance</term><term>Travel</term><term>United States (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Afrique (épidémiologie)</term><term>Angleterre (épidémiologie)</term><term>Australie (épidémiologie)</term><term>Canada (épidémiologie)</term><term>Donneurs de sang</term><term>France (épidémiologie)</term><term>Humains</term><term>Maladies endémiques</term><term>Paludisme ()</term><term>Paludisme (diagnostic)</term><term>Paludisme (transmission)</term><term>Paludisme (épidémiologie)</term><term>Politique de santé</term><term>Surveillance de la santé publique</term><term>Sécurité transfusionnelle ()</term><term>Sécurité transfusionnelle (normes)</term><term>Sélection de donneurs (normes)</term><term>Transfusion sanguine (effets indésirables)</term><term>Transfusion sanguine (normes)</term><term>Voyage</term><term>Émigration et immigration</term><term>États-Unis d'Amérique (épidémiologie)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Africa</term><term>Australia</term><term>Canada</term><term>England</term><term>France</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Blood Transfusion</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Malaria</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Paludisme</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Transfusion sanguine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Malaria</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Blood Safety</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Sécurité transfusionnelle</term><term>Sélection de donneurs</term><term>Transfusion sanguine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Malaria</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Blood Safety</term><term>Blood Transfusion</term><term>Donor Selection</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Malaria</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Afrique</term><term>Angleterre</term><term>Australie</term><term>Canada</term><term>France</term><term>Paludisme</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Blood Donors</term><term>Emigration and Immigration</term><term>Endemic Diseases</term><term>Health Policy</term><term>Humans</term><term>Public Health Surveillance</term><term>Travel</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Donneurs de sang</term><term>Humains</term><term>Maladies endémiques</term><term>Paludisme</term><term>Politique de santé</term><term>Surveillance de la santé publique</term><term>Sécurité transfusionnelle</term><term>Voyage</term><term>Émigration et immigration</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term><term>Canada</term><term>France</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Addressing risk of imported malaria is complicated by 5 human species of Plasmodium, semi-immunity in donors with long-term exposure, increasing travel and immigration, changing risk in endemic areas, and limitations of screening assays. To gain insight into policy formulation, we have compiled epidemiologic data from 5 countries with different policies involving either deferral (the United States and Canada) or selective testing (France, England, and Australia). The greatest risk is from semi-immune former residents of endemic areas, but the greatest impact on sufficiency (donor loss) is from low-risk short-term travel. France and the UK have the highest rates of travel to Africa where most malaria cases originate. The UK has substantial travel to the Indian subcontinent where Plasmodium vivax cases are more common, and Australia, to Southeast Asia and Papua New Guinea. In the United States and Canada, malaria risk travel is more often to lower risk areas such as Mexico and the Caribbean. Each country has imported cases, predominantly Plasmodium falciparum and P. vivax, although data are incomplete. Transfusion-transmitted malaria has been rare over the last 10 years, generally involving P. falciparum, but there were 2 US cases of Plasmodium malariae. Uncertainty due to limitations of epidemiologic data and reliance on donors' answers underpins much of the complexity of policy formulation. Variability in policies between countries reflects not only epidemiologic differences but also operational considerations, donor demographics, regulatory approaches, and public pressure to react to rare transfusion-transmitted malaria cases. Testing reduces the operational impact of addressing the very small risk from travelers and offers improvement over deferral by testing all former residents of endemic areas. Notwithstanding current international regulatory requirements, policies have "evolved" through a series of additions and revisions as concerns and issues arose, with resultant variability in donor selection criteria.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25933591</PMID><DateCreated><Year>2015</Year><Month>06</Month><Day>13</Day></DateCreated><DateCompleted><Year>2016</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-9496</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Transfusion medicine reviews</Title><ISOAbbreviation>Transfus Med Rev</ISOAbbreviation></Journal><ArticleTitle>The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.</ArticleTitle><Pagination><MedlinePgn>162-71</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmrv.2015.03.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0887-7963(15)00044-9</ELocationID><Abstract><AbstractText>Addressing risk of imported malaria is complicated by 5 human species of Plasmodium, semi-immunity in donors with long-term exposure, increasing travel and immigration, changing risk in endemic areas, and limitations of screening assays. To gain insight into policy formulation, we have compiled epidemiologic data from 5 countries with different policies involving either deferral (the United States and Canada) or selective testing (France, England, and Australia). The greatest risk is from semi-immune former residents of endemic areas, but the greatest impact on sufficiency (donor loss) is from low-risk short-term travel. France and the UK have the highest rates of travel to Africa where most malaria cases originate. The UK has substantial travel to the Indian subcontinent where Plasmodium vivax cases are more common, and Australia, to Southeast Asia and Papua New Guinea. In the United States and Canada, malaria risk travel is more often to lower risk areas such as Mexico and the Caribbean. Each country has imported cases, predominantly Plasmodium falciparum and P. vivax, although data are incomplete. Transfusion-transmitted malaria has been rare over the last 10 years, generally involving P. falciparum, but there were 2 US cases of Plasmodium malariae. Uncertainty due to limitations of epidemiologic data and reliance on donors' answers underpins much of the complexity of policy formulation. Variability in policies between countries reflects not only epidemiologic differences but also operational considerations, donor demographics, regulatory approaches, and public pressure to react to rare transfusion-transmitted malaria cases. Testing reduces the operational impact of addressing the very small risk from travelers and offers improvement over deferral by testing all former residents of endemic areas. Notwithstanding current international regulatory requirements, policies have "evolved" through a series of additions and revisions as concerns and issues arose, with resultant variability in donor selection criteria.</AbstractText><CopyrightInformation>Copyright © 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Sheila F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Canadian Blood Services Ottawa, Ontario, Canada. Electronic address: sheila.obrien@blood.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delage</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Héma-Québec Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seed</LastName><ForeName>Clive R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Australian Red Cross Blood Service Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillonel</LastName><ForeName>Josiane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut de Veille Sanitaire, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabra</LastName><ForeName>Cécile C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Établissement Français du Sang Tours, Indre-et-Loire, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Katy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Protection Agency, Centre for Infections, London, UK; NHS Blood and Transplant, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitchen</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Whitney R</ForeName><Initials>WR</Initials><AffiliationInfo><Affiliation>American Red Cross Holland Laboratory, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leiby</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>American Red Cross Holland Laboratory, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfus Med Rev</MedlineTA><NlmUniqueID>8709027</NlmUniqueID><ISSNLinking>0887-7963</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="N">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058731" MajorTopicYN="N">Blood Safety</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046148" MajorTopicYN="N">Donor Selection</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004641" MajorTopicYN="Y">Emigration and Immigration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019353" MajorTopicYN="N">Endemic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062486" MajorTopicYN="N">Public Health Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014195" MajorTopicYN="Y">Travel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Blood donor</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Malaria</Keyword><Keyword MajorTopicYN="N">Policy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>03</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25933591</ArticleId><ArticleId IdType="pii">S0887-7963(15)00044-9</ArticleId><ArticleId IdType="doi">10.1016/j.tmrv.2015.03.004</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002B49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25933591
|texte= The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25933591" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |